Name | N-[2-[bis(1,1,2,2,2-pentadeuterioethyl)amino]ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
---|---|
Synonyms |
Sunitinib-d10
Sutent-d10 |
Description | Sunitinib D10 (SU 11248 D10) is a deuterium labeled Sunitinib. Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively[1]. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation[2]. |
---|---|
Related Catalog | |
Target |
VEGFR2:80 nM (IC50) PDGFRβ:2 nM (IC50) |
References |
Molecular Formula | C22H17D10FN4O2 |
---|---|
Molecular Weight | 408.53500 |
Exact Mass | 408.27500 |
PSA | 84.21000 |
LogP | 3.99480 |
Hazard Codes | Xi |
---|